FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to ortho-antranilamide derivatives of the formula (I): wherein A means =CH- or =N; m means a whole number 1-3; n means a whole number 1-4; D means -N(R5)-C(Z)- or -N(R5)-S(O)p- (wherein p means 0-2; Z means oxygen or sulfur atom or H2, and nitrogen atom is bound with phenyl ring comprising substituents R1 and R2); E means C(Z)-N(R5)- or -S(O)p-N(R5)- (wherein p means 0-2; Z means oxygen or sulfur atom or H2 and nitrogen atom can be bound with phenyl ring comprising substituents R1 and R2 or with aromatic ring comprising a substituent R4). Compounds inhibit the enzyme, factor Xa, owing to they can be used as anti-coagulating agents. Invention describes pharmaceutical composition and method for treatment using compounds of the formula (I) also. EFFECT: valuable medicinal properties of compounds. 66 cl, 54 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVE OF 2-ARYLETHYL-(PIPERIDINE-4-YLMETHYL)-AMINE AND MEDICINAL AGENT | 1999 |
|
RU2220138C2 |
PURINE DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT | 1997 |
|
RU2191778C2 |
METHOD FOR TREATMENT OF STATES CAUSED BY p38 KINASES AND PYRROLOTRIAZINE COMPOUNDS USED AS KINASE INHIBITORS | 2001 |
|
RU2316556C2 |
Axl INHIBITORS APPLICABLE IN COMBINATION THERAPY FOR PREVENTING, RELIEVING OR TREATING METASTATIC CANCER | 2010 |
|
RU2555326C2 |
PLASMA CARBOXYPEPTIDASE B INHIBITORS | 2003 |
|
RU2323223C2 |
PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | 2004 |
|
RU2326118C2 |
ALKYLSUPHINYL-SUBSTITUTED THIAZOLIDE COMPOUNDS | 2011 |
|
RU2605745C2 |
IAP INHIBITORS | 2006 |
|
RU2451025C2 |
SPIROHETEROCYCLIC COMPOUNDS AND USE THEREOF AS THERAPEUTIC AGENTS | 2006 |
|
RU2428424C2 |
THERAPEUTIC COMPOUNDS AND COMPOSITIONS | 2015 |
|
RU2733405C2 |
Authors
Dates
2004-04-10—Published
1998-11-27—Filed